Role & Responsibilities:• Strategy and selection of right product mix to maximize revenue growth and profits.• Develop Go-to market strategy and implementation of the same. • Create a formidable brand in this segment.• Build, train and grow a sales team to implement the marketing strategies.• Explore and expand new territories to increase market share.• Work with multiple stakeholders such as contract manufacturer, channel distributors and health providers.• Financial management of operations including cash flow management.• Manage and maintain administrative affairs of the organization.• Ensure compliance to statutory and regulatory requirements.

• • Looking after the marketing and sales operations for Cipla (All the Products), Lupin & Alkem (Some Products) in the ETC Segment, A team of 2 Business Managers are reporting to me • Looking after the Marketing and sales operations for the OTC Division of the Company • A team 40 Medical sales representative,5 Manager’s, 1 National Manager, 1 Marketing Manager and a team of 10 Telesales (Digital Marketing) department are reporting to me in the OTC Division • New product identification especially in the OTC and Launch Plan for the New Products• Exploring New Territories to increase market share.• Maintaining good business relations with Trading Agents, Pharmaceutical Wholesaler, Importer• Designing and applying marketing and pricing strategies to the company.

Role & Responsibility; • Looking after the marketing and sales operations. • A team of 20 Medical Representative, 4 Manager’s and 3 Office staff are reporting to me.• Laisoning with MoH [National Drug Authority] to get swift product registration as well as getting approval for doing various brand promotions activities. • Trade mark registration, New product identification• Exploring New Territories to increase market share.• Maintaining good business relations with local manufacturers, Hospital authorities for the effective participation of hospital tenders. • Designing and applying marketing and pricing strategies to the company.• Organizing seminars and CMEs with doctors for effective Promotion of products. ( More than 50 CME ‘s are conducted in the Various segments like Cardiology, Psychiatric, Neurology, Oncology ,Gastro and Penem Antibiotics)Major Achievements:• Created an effective distribution & centralized communication system, which created a consistent relation with the customer & helped to raise the sales from “30 K” per annum to 4 M USD per annum• Supported for the breakthrough in Cambodia market by winning prestigious government sponsored tender & initiated ‘Sun Pharma’ Product over there through NGO (1 M USD sales per year) and also did the Regulatory work for the Product Registration (Nearly 10 Products got registered) • With an effective co-ordination with MOH (Ministry of Health) & Regulatory affairs we had registered more than 50 Products• Launched Liposomal Doxorubicin and entered in Hospital tender list of some of Major Hospitals in the North and central Vietnam( 1 M USD per Year)• Sun Products are available in Almost of the Hospitals through tender in the North and Central Vietnam and all the Prestigious Hospital’s the Products are available in the Hospital Insurance System •

1. Managing sales and Marketing for the assigned territories ( North and Central Vietnam)2. Exploring new markets for the Business development 3. Regulatory activities 4. New Product selection

Responsibilities:• Looking after the marketing, sales & administration operations.• Coordinating, Training, Motivating & Monitoring of medical representatives, Sales & marketing staff• Laisoning with MoH (Ministry Of Health), for the effective registration & import Quotas. • handling of National & Provincial distributors, Major Achievements: • In the span of “2” years effectively supported organisation to get the Visas & Quotas(Temporary registrations) for around ‘50” products, which helped to boost the sales to “six” times (i.e.) from USD-500,000 to USD-3,000,000, which includes marketing as well as trading • Become a brand leader for “AZIFLAM”(Azithromycin) & “LEXIN”(Cephalexin) with a market share of 30 & 50% respectively